Downloads provided by UsageCounts
This is Matthew Todd's presentation at the monthly [virtual] Antiviral Drug Discovery (AViDD) Open Science Forum on 16 November 2022. Their talk centers around the druggability of SARS-CoV-2 nsp13. SGC nsp13 Open Lab Notebook You can find a recording of their talk on the AViDD Open Science Forum Youtube page Mat Todd is a part of the Rapidly Emerging Antiviral Drug Development Initiative (READDI)
Antiviral Drug Discovery, AViDD, Open Science, Rapidly Emerging Antiviral Drug Development Initiative (READDI), Open Science Forum, Antiviral Drug Discovery Open Science Forum, AViDD Open Science Forum
Antiviral Drug Discovery, AViDD, Open Science, Rapidly Emerging Antiviral Drug Development Initiative (READDI), Open Science Forum, Antiviral Drug Discovery Open Science Forum, AViDD Open Science Forum
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
| views | 6 | |
| downloads | 14 |

Views provided by UsageCounts
Downloads provided by UsageCounts